Free Trial

Callan Family Office LLC Has $908,000 Stock Position in Amdocs Limited $DOX

Amdocs logo with Computer and Technology background

Key Points

  • Callan Family Office LLC has increased its stake in Amdocs Limited by 157.1%, owning 9,952 shares valued at approximately $908,000 as of their latest SEC filing.
  • Amdocs recently declared a quarterly dividend of $0.527 per share, with an annualized dividend yield of 2.6%, payable on October 31st.
  • The company reported $1.72 earnings per share for the last quarter, slightly beating analyst expectations, despite an 8.4% year-over-year revenue decline.
  • Five stocks we like better than Amdocs.

Callan Family Office LLC lifted its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 157.1% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,952 shares of the technology company's stock after buying an additional 6,081 shares during the quarter. Callan Family Office LLC's holdings in Amdocs were worth $908,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of DOX. Alyeska Investment Group L.P. lifted its holdings in shares of Amdocs by 38.6% during the first quarter. Alyeska Investment Group L.P. now owns 2,329,767 shares of the technology company's stock worth $213,174,000 after buying an additional 648,693 shares in the last quarter. American Century Companies Inc. increased its position in shares of Amdocs by 23.5% in the first quarter. American Century Companies Inc. now owns 2,242,829 shares of the technology company's stock worth $205,219,000 after purchasing an additional 426,911 shares during the period. Nuveen LLC bought a new position in shares of Amdocs in the first quarter worth $36,921,000. LSV Asset Management increased its position in shares of Amdocs by 11.1% in the first quarter. LSV Asset Management now owns 3,180,501 shares of the technology company's stock worth $291,016,000 after purchasing an additional 317,412 shares during the period. Finally, AQR Capital Management LLC increased its position in shares of Amdocs by 43.0% in the first quarter. AQR Capital Management LLC now owns 955,158 shares of the technology company's stock worth $86,719,000 after purchasing an additional 287,243 shares during the period. Institutional investors and hedge funds own 92.02% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently commented on DOX. Weiss Ratings restated a "hold (c+)" rating on shares of Amdocs in a research report on Wednesday, October 8th. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday. Finally, Wolfe Research began coverage on Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating on the stock. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Amdocs currently has a consensus rating of "Moderate Buy" and an average target price of $108.00.

Get Our Latest Research Report on Amdocs

Amdocs Stock Performance

Amdocs stock opened at $80.77 on Monday. Amdocs Limited has a 12-month low of $78.61 and a 12-month high of $95.41. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The business's 50-day moving average price is $84.82 and its two-hundred day moving average price is $87.68. The stock has a market cap of $9.12 billion, a PE ratio of 16.38, a P/E/G ratio of 1.34 and a beta of 0.51.

Amdocs (NASDAQ:DOX - Get Free Report) last released its earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion for the quarter, compared to analysts' expectations of $1.13 billion. During the same quarter in the previous year, the business posted $1.62 earnings per share. The business's revenue for the quarter was down 8.4% on a year-over-year basis. As a group, analysts expect that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is presently 42.80%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.